Seed Wealth Management’s GSK GSK Stock Holding History

Seed Wealth Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$319K	Hold	6,080	–	–	0.2%	72
2026 Q1	$336K	Hold	6,080	–	–	0.23%	64
2025 Q4	$298K	Hold	6,080	–	–	0.21%	76
2025 Q3	$262K	Sell	6,080 -1,020	-14%	-$39.8K	0.18%	90
2025 Q2	$273K	Sell	7,100 -420	-6%	-$16K	0.2%	118
2025 Q1	$291K	Hold	7,520	–	–	0.24%	107
2024 Q4	$254K	Hold	7,520	–	–	0.21%	119
2024 Q3	$307K	Hold	7,520	–	–	0.25%	103
2024 Q2	$290K	Buy	7,520 +420	+6%	+$17.7K	0.25%	100
2024 Q1	$301K	Sell	7,100 -120	-2%	-$4.95K	0.29%	89
2023 Q4	$271K	Hold	7,220	–	–	0.27%	96
2023 Q3	$262K	Hold	7,220	–	–	0.29%	92
2023 Q2	$257K	Hold	7,220	–	–	0.27%	96
2023 Q1	$257K	Hold	7,220	–	–	0.29%	89
2022 Q4	$254K	Buy	+7,220	New	+$240K	0.29%	87

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Seed Wealth Management's GSK Position: Q2 2026 in Review

Seed Wealth Management held its GSK (GSK) position steady in Q2 2026 at 6,080 shares worth $319K. The position accounts for 0.2% of the portfolio, ranked #72.

Seed Wealth Management first reported a position in GSK in Q4 2022 and has held it in 15 quarters since. The position peaked at $336K in Q1 2026. 1,040 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

Seed Wealth Management held 6,080 shares of GSK worth $319K as of Q2 2026.
Seed Wealth Management left its GSK share count unchanged in Q2 2026.
GSK made up 0.2% of Seed Wealth Management's portfolio in Q2 2026, its #72 holding.
Seed Wealth Management first reported a position in GSK in Q4 2022 and has held it in 15 quarters since.
Seed Wealth Management's GSK position peaked at $336K in Q1 2026.
1,040 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Seed Wealth Management's 13F filing for Q2 2026, filed 27 Jul 2026.